Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
Patients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we charac...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The MIT Press
2018-02-01
|
Series: | Computational Psychiatry |
Subjects: | |
Online Access: | https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011 |
id |
doaj-9e037f2ef0e4418cabe0e5c7c875f6e5 |
---|---|
record_format |
Article |
spelling |
doaj-9e037f2ef0e4418cabe0e5c7c875f6e52020-11-24T23:29:16ZengThe MIT PressComputational Psychiatry2379-62272018-02-012112710.1162/CPSY_a_00011CPSY_a_00011Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)Monique H. M. Timmer0Guillaume Sescousse1Rianne A. J. Esselink2Payam Piray3Roshan Cools4Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDepartment of Psychiatry, Radboud University Medical Centre, Nijmegen, the NetherlandsPatients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we characterize the computational mechanisms that contribute to dopamine-induced changes in risky choice in PD patients with and without a depression (history). We adopt a clinical–neuroeconomic approach to investigate the effects of dopaminergic medication on specific components of risky choice in PD. Twenty-three healthy controls, 21 PD patients with a depression (history), and 22 nondepressed PD patients were assessed using a well-established risky choice paradigm. Patients were tested twice: once after taking their normal dopaminergic medication and once after withdrawal of their medication. Dopaminergic medication increased a value-independent gambling propensity in nondepressed PD patients, while leaving loss aversion unaffected. By contrast, dopaminergic medication effects on loss aversion were associated with current depression severity and with drug effects on depression scores. The present findings demonstrate that dopaminergic medication increases a value-independent gambling bias in nondepressed PD patients. Moreover, the current study raises the hypothesis that dopamine-induced reductions in loss aversion might underlie previously observed comorbidity between depression and medication-related side effects in PD, such as impulse control disorder.https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011Parkinson’s diseasedepressionrisky choicedopamineloss aversionprospect theory |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Monique H. M. Timmer Guillaume Sescousse Rianne A. J. Esselink Payam Piray Roshan Cools |
spellingShingle |
Monique H. M. Timmer Guillaume Sescousse Rianne A. J. Esselink Payam Piray Roshan Cools Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) Computational Psychiatry Parkinson’s disease depression risky choice dopamine loss aversion prospect theory |
author_facet |
Monique H. M. Timmer Guillaume Sescousse Rianne A. J. Esselink Payam Piray Roshan Cools |
author_sort |
Monique H. M. Timmer |
title |
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) |
title_short |
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) |
title_full |
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) |
title_fullStr |
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) |
title_full_unstemmed |
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) |
title_sort |
mechanisms underlying dopamine-induced risky choice in parkinson’s disease with and without depression (history) |
publisher |
The MIT Press |
series |
Computational Psychiatry |
issn |
2379-6227 |
publishDate |
2018-02-01 |
description |
Patients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we characterize the computational mechanisms that contribute to dopamine-induced changes in risky choice in PD patients with and without a depression (history). We adopt a clinical–neuroeconomic approach to investigate the effects of dopaminergic medication on specific components of risky choice in PD. Twenty-three healthy controls, 21 PD patients with a depression (history), and 22 nondepressed PD patients were assessed using a well-established risky choice paradigm. Patients were tested twice: once after taking their normal dopaminergic medication and once after withdrawal of their medication. Dopaminergic medication increased a value-independent gambling propensity
in nondepressed PD patients, while leaving loss aversion unaffected. By contrast, dopaminergic medication effects on loss aversion were associated with current depression severity and with drug effects on depression scores. The present findings demonstrate that dopaminergic medication increases a value-independent gambling bias in nondepressed PD patients. Moreover, the current study raises the hypothesis that dopamine-induced reductions in loss aversion might underlie previously observed comorbidity between depression and medication-related side effects in PD, such as impulse control disorder. |
topic |
Parkinson’s disease depression risky choice dopamine loss aversion prospect theory |
url |
https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011 |
work_keys_str_mv |
AT moniquehmtimmer mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory AT guillaumesescousse mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory AT rianneajesselink mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory AT payampiray mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory AT roshancools mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory |
_version_ |
1725546520240979968 |